The 100th unit of MultiSource® HDR Co-60 afterloader completed the installation in Bangkok, Thailand

2009-10-06 Page Views : 173 Author : Admin

Important Notes:

In January 2021, BEBIG Medical GmbH took over the global production and distribution structures of the HDR brachytherapy products of Eckert & Ziegler BEBIG GmbH including Mick Radio-Nuclear Instruments, Inc.

Below news are related to the HDR brachytherapy business and is quoted originally from the website: https://www.ezag.com/home/press/press_releases/detail/?tx_ttnews%5Btt_news%5D=204&cHash=5464b20153bea52e308dd1f80c786809 

Original Content:

Belgian Medical Device Company International Brachytherapy S.A. (IBt Bebig), a portfolio company of Eckert & Ziegler AG (ISIN DE0005659700) has completed the installation of a MultiSource® Co-60 HDR (High Dose Rate) afterloader equipment in the Vajira Hospital in Bangkok, Thaïland. This center represents the 100th medical center in the world that has opted for the temporary brachytherapy solution proposed by IBt Bebig to treat certain types of cancer by internal irradiation.

The Vajira Hospital in Bangkok is expecting to use this irradiator to primarily treat gynecological, breast and neck cancer tumors. Dr Thanatip Tantivatana, Head of Division of Radiation Oncology, has declarred:"After a thorough analysis and comparision of the different technologies proposed, we have chosen the MultiSource® HDR brachytherapy afterloader of IBt Bebig because of its unique technology using a miniaturized Co-60 source and the associated very efficient, low teatment cost."

The MultiSource® Co-60 High Dose Rate afterloader equipment manufacturered by IBt Bebig is now being in use in moe than 20 countries around the world. "This installation reprents an impotant symbolic milestone for the group. It is also a strong indication of the inceased level of recognition and of the value fo our world unique Co-60 irradiation source technology", commented Mr. Francois Blodel, CEO of IBt Bebig. "We are now expecting to significantly expand our market coverage over the next two to three years and proceed, over this timeframe, with the installation of an additional 100 afterloaders HDR temporary brachytherapy machiness, generating in excess of 20 million EUR of revenues for the group", he added.

The Multisource® is a medical device equipment that allows to perfom the temporary brachytherapy treatment of cancers. Using a radioactive source (either Ir-192 or Co-60) contained and shielded in a trolley, catthetters are inserted by the physician into the body and allow for a "temporary implant" to be positioned directly inside the tumor ("remote afterloading" technique).

About BEBIG Medical GmbH:

BEBIG Medical GmbH (“BEBIG Medical”) is a global provider of high quality radiation therapy products for cancer treatment headquartered in Berlin, Germany. Preceded by the high dose brachytherapy business unit of Eckert & Ziegler AG, BEBIG Medical has a heritage of more than 40 years’ experience in brachytherapy field and continues to provide affordable healthcare with proven clinical outcomes via strong and viable technology.BEBIG Medical’s US subsidiary, Mick Radio-Nuclear Instruments, Inc., is also known internationally for its manufacturing expertise in the field of applicators and accessories to advance brachytherapy. With a team of professionals and offices in Europe, United States and Asia, the company is empowered to serve customers in more than 65 countries and regions together with a worldwide distribution network.



Crystal Chen, Chief Commercial Officer: crystal.chen@bebigmedical.com

Related News
+49 30 9487888-10
Robert-Rössle-Str. 10, 13125 Berlin Germany

Copyright © BEBIG Medical. All rights reserved.